{ "items": [ "\n\n
\n \n 16 November 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Pandemic Sciences Institute has joined forces with the Science for Africa Foundation and the Mastercard Foundation to launch a call for applications to establish innovative networks of research excellence in epidemic and pandemic sciences across Africa.
\n \n\n\n \n 15 November 2023\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nA recent study led by researchers at NDM uncovered details of the process by which germinal centres help to improve the immune response over time.
\n \n\n\n \n 14 November 2023\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nA study by NDM\u2019s CAMS Oxford Institute and MRC Translational Immune Discovery Unit gives insights into how immune cells interact in the lungs of severe COVID-19 patients.
\n \n\n\n \n 13 November 2023\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Deirdre Hollingsworth, Professor of Infectious Disease Epidemiology at NDM\u2019s Big Data Institute and Centre for Tropical Medicine and Global Health, has been named one of this year\u2019s 50 Leading Lights for Kindness & Leadership in the UK. This campaign highlights the leaders who are impacting others through kindness.
\n \n\n\n \n 10 November 2023\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nThe first-ever crowd-sourced small molecule discovery effort has been published in Science, describing the open-science discovery of a strong antiviral for SARS-CoV-2, paving the way for potential antivirals for all coronaviruses.
\n \n\n\n \n 9 November 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe AIDS Clinical Trials Group is starting a study to test a new HIV treatment. The study will enrol participants who initiated HIV treatment shortly after getting infected with HIV.
\n \n\n\n \n 8 November 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe University of Oxford has announced a partnership with Danaher Corporation to develop a new test to enable precision medicine care for sepsis, a pathological immune response to infection that accounts for one in five deaths globally each year.
\n \n\n\n \n 7 November 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Global Health Network and the British Society for Antimicrobial Chemotherapy (BSAC) have signed a Memorandum of Understanding (MoU) establishing a framework for collaboration that can maximise the impact of shared antimicrobial resistance education, policy and advocacy efforts.
\n \n\n\n \n 6 November 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nScientific advisors to the International Pandemic Preparedness Secretariat (IPPS) visited the University of Oxford\u2019s vaccine laboratories as part of a two-day meeting of the global coalition.
\n \n\n\n \n 3 November 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford announced the launch of a new project to initiate early development of prototype vaccines against the Jun\u00edn virus. This is the first project to be initiated under CEPI and the University of Oxford\u2019s strategic partnership to accelerate global pandemic preparedness efforts.
\n \n\n\n \n 2 November 2023\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe AELIX-002 study group research was awarded the European Hector Research Award in HIV for research on the therapeutic vaccine against HIV. The researchers include Prof Tom\u00e1\u0161 Hanke, Professor of Vaccine Immunology at the Jenner Institute at NDM.
\n \n\n\n \n 1 November 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nNDM\u2019s Oxford University Clinical Research Unit in Viet Nam will be a part of a new initiative aimed at developing a strategic roadmap for Ho Chi Minh City to become a regional Health Innovation Hub. The project, supported by a \u00a375,000 grant from the UK Government, is a strategic move to transform Ho Chi Minh City into ASEAN's leading health innovation centre.
\n \n\n\n \n 30 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial, which discovered four effective treatments for COVID-19, has now expanded to investigate treatments for influenza (flu). The RECOVERY trial is a collaboration between the Nuffield Department of Medicine and the Nuffield Department of Population Health.
\n \n\n\n \n 27 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Philippe Gu\u00e9rin, Director of the Infectious Diseases Data Observatory and WorldWide Antimalarial Network, has been awarded the Bailey K. Ashford Medal for his 'distinguished' work in tropical medicine.
\n \n\n\n \n 26 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Broad One Health Endectocide-based Malaria Intervention in Africa project (BOHEMIA) begins its mass drug administration (MDA) activities in Kenya\u2019s Kwale County. BOHEMIA is a consortium of multiple international organisations including the Centre for Tropical Medicine and Global Health at NDM.
\n \n\n\n \n 25 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Arjen Dondorp has been awarded the highly prestigious 2023 George Macdonald Medal. This medal recognises outstanding contributions to conducting research leading to significant improvements in health in the tropics. It is a joint award from the London School of Hygiene & Tropical Medicine (LSHTM) and the Royal Society of Tropical Medicine & Hygiene (RSTMH).
\n \n\n\n \n 24 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nIn a recent study, multidisciplinary researchers and specialists of an international consortium, including those from NDM, have developed a new method to counter the problem of COVID-19 vaccine falsification.
\n \n\n\n \n 23 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nIn a recent study, researchers at the Pandemic Sciences Institute, bring together for the first time, the epidemiology and evolution of the SARS-CoV-2 virus in the UK during the first three years of the pandemic \u2013 including how variants emerged and spread.
\n \n\n\n \n 20 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nIn collaboration with Ho Chi Minh City's healthcare sector, NDM's Oxford University Clinical Research Unit has successfully identified the primary agent causing the outbreak of pink eye disease. Testings revealed an unexpected finding: enterovirus was the primary agent, contrary to previous reports from Vietnam wherein adenovirus was the culprit.
\n \n\n\n \n 19 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nAn estimated 95,000\u2013167,000 inpatients at English National Health Service (NHS) hospitals caught SARS-CoV-2 while in hospital during England\u2019s \u2018second wave\u2019 of COVID-19, between June 2020 and March 2021, reports a study in Nature. The findings reveal the scale of hospital transmissions and highlight contributing factors, such as a limited number of single rooms.
\n \n\n